SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,000 | +20.7% | 10,119 | +61.3% | 0.00% | – |
| Q2 2023 | $29,000 | +61.1% | 6,275 | +57.4% | 0.00% | – |
| Q1 2023 | $18,000 | -70.0% | 3,986 | -46.5% | 0.00% | – |
| Q4 2022 | $60,000 | +1900.0% | 7,451 | +1150.2% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 596 | +141.3% | 0.00% | – |
| Q2 2022 | $1,000 | -96.2% | 247 | -92.1% | 0.00% | – |
| Q1 2022 | $26,000 | -80.3% | 3,133 | -64.9% | 0.00% | – |
| Q4 2021 | $132,000 | +428.0% | 8,920 | +571.2% | 0.00% | – |
| Q3 2021 | $25,000 | +212.5% | 1,329 | +206.2% | 0.00% | – |
| Q2 2021 | $8,000 | -87.1% | 434 | -84.0% | 0.00% | – |
| Q1 2021 | $62,000 | +520.0% | 2,716 | +462.3% | 0.00% | – |
| Q4 2020 | $10,000 | – | 483 | +1912.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 24 | -97.9% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 1,159 | +17.2% | 0.00% | – |
| Q4 2019 | $11,000 | – | 989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |